Skip to main content
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · IEX Real-Time Price · USD
3.090
-0.050 (-1.59%)
At close: May 17, 2024, 4:00 PM
3.080
-0.010 (-0.32%)
After-hours: May 17, 2024, 7:29 PM EDT

Taysha Gene Therapies Revenue

Taysha Gene Therapies had revenue of $14.16M in the twelve months ending March 31, 2024, with 96.39% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.41M, a -27.52% decrease year-over-year. In the year 2023, Taysha Gene Therapies had annual revenue of $15.45M with 517.55% growth.

Revenue (ttm)
$14.16M
Revenue Growth
+96.39%
P/S Ratio
40.76
Revenue / Employee
$272,231
Employees
52
Market Cap
576.95M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202315.45M12.95M517.55%
Dec 31, 20222.50M--
Dec 31, 20210--
Dec 31, 20200--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

TSHA News

More News